<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xml:lang="en">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)</title>
        <author>Ben Kirk</author>
        <author>Peggy M. Cawthon</author>
        <author>Hidenori Arai</author>
        <author>José Alberto Ávila‐Funes</author>
        <author>Rocco Barazzoni</author>
        <author>Shalender Bhasin</author>
        <author>Ellen F. Binder</author>
        <author>Olivier Bruyère</author>
        <author>Tommy Cederholm</author>
        <author>Liang‐Kung Chen</author>
        <author>Cyrus Cooper</author>
        <author>Gustavo Duque</author>
        <author>Roger A. Fielding</author>
        <author>Jack M. Guralnik</author>
        <author>Douglas P. Kiel</author>
        <author>Francesco Landi</author>
        <author>Jean‐Yves Reginster</author>
        <author>Avan Aihie Sayer</author>
        <author>Marjolein Visser</author>
        <author>Stephan von Haehling</author>
        <author>Jean Woo</author>
        <author>Alfonso J. Cruz‐Jentoft</author>
        <author>The Global Leadership Initiative in Sarcopenia (GLIS) group</author>
        <author>Alberto Frisoli Júnior</author>
        <author>Andrea B. Maier</author>
        <author>Anne B. Newman</author>
        <author>Anton De Spiegeleer</author>
        <author>Antoneta Granic</author>
        <author>Antonio Cherubini</author>
        <author>Assim M. AlAbdulKader</author>
        <author>Charlotte Beaudart</author>
        <author>Brian C. Clark</author>
        <author>Todd T. Brown</author>
        <author>Carla M. Prado</author>
        <author>Carolyn Greig</author>
        <author>Chang Won Won</author>
        <author>Charlotte Suetta</author>
        <author>Chih‐Kuang Liang</author>
        <author>Christopher Hurst</author>
        <author>Daniel Rooks</author>
        <author>David G. Le Couteur</author>
        <author>David Scott</author>
        <author>Debra L. Waters</author>
        <author>Dolores Sánchez‐Rodríguez</author>
        <author>Esmee M. Reijnierse</author>
        <author>Eva Topinková</author>
        <author>Fanny Petermann‐Rocha</author>
        <author>Finbarr C. Martin</author>
        <author>Gülistan Bahat</author>
        <author>Haya F. Alhmly</author>
        <author>Iván Aprahamian</author>
        <author>Jae‐Young Lim</author>
        <author>Jean‐Pierre Michel</author>
        <author>Jesse Zanker</author>
        <author>John A. Batsis</author>
        <author>John А. Kanis</author>
        <author>Joshua R. Lewis</author>
        <author>Juergen Bauer</author>
        <author>Julie A. Pasco</author>
        <author>Justin Keogh</author>
        <author>Kaisu Pitkälä</author>
        <author>Ken Madden</author>
        <author>Kenji Toba</author>
        <author>Kristina Norman</author>
        <author>L. Schaap</author>
        <author>Lin Kang</author>
        <author>Li‐Ning Peng</author>
        <author>Lisa K. Micklesfield</author>
        <author>C.P.G.M. de Groot</author>
        <author>Lorenzo M. Donini</author>
        <author>Marc Sim</author>
        <author>Marı́a Cristina González</author>
        <author>Marie-Josiane Ntsama Essomba</author>
        <author>Masafumi Kuzuya</author>
        <author>Mathis Grossmann</author>
        <author>Matteo Cesari</author>
        <author>Michael Tieland</author>
        <author>Miles D. Witham</author>
        <author>Ming-Yueh Chou</author>
        <author>Minoru Yamada</author>
        <author>Miranda D. Grounds</author>
        <author>Pedro Abizanda Soler</author>
        <author>Qian‐Li Xue</author>
        <author>Rachel Cooper</author>
        <author>Rainer Wirth</author>
        <author>Renuka Visvanathan</author>
        <author>Reshma Aziz Merchant</author>
        <author>René Rizzoli</author>
        <author>Robin M. Daly</author>
        <author>Sebastiana Kalula</author>
        <author>Siân Robinson</author>
        <author>Stany Perkisas</author>
        <author>S. Schneider</author>
        <author>Steven B. Heymsfield</author>
        <author>Steven Phu</author>
        <author>Stuart M. Phillips</author>
        <author>Sun Young Kim</author>
        <author>Suzette L. Pereira</author>
        <author>Thomas E. Gill</author>
        <author>Tomasz Grodzicki</author>
        <author>Tomasz Kostka</author>
        <author>Tung‐Wai Auyeung</author>
        <author>Wee Shiong Lim</author>
        <author>Wei‐Ju Lee</author>
        <author>Yasmin Algindan</author>
        <author>Yosuke Yamada</author>
        <author>Yunhwan Lee</author>
        <author>Yves Boirie‌</author>
        <author>Yvette C. Luiking</author>
      </titleStmt>
      <publicationStmt>
        <p>Tag layer of the DHSS Meta-Tagging Project. The article text is reproduced from the
           staged copy named in sourceDesc and is not altered; the tags are held separately in
           standOff so that overlapping and nested spans are preserved.</p>
      </publicationStmt>
      <sourceDesc>
        <bibl>
          <title>The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)</title>
          <date>2024</date>
          <publisher>Age and Ageing</publisher>
          <idno type="DOI">10.1093/ageing/afae052</idno>
          
          <idno type="record">kirk2024-the-conceptual-definition-of-sarco</idno>
          <note type="staged-file">kirk2024-the-conceptual-definition-of-sarco.txt, the project's staged copy</note>
          <note type="text-sha1">fac32e2ca9d64103b04a078ada4f8ce9907f9b2d</note>
          <note type="rights">cc-by-nc</note>
        </bibl>
      </sourceDesc>
    </fileDesc>
    <profileDesc>
      <textClass><keywords><term>medicine</term></keywords></textClass>
      <particDesc>
        <person xml:id="paper"><p>the paper's own words</p></person>
        <person xml:id="tagger"><p>the tag layer; a sentence written by the tagger about the
          paper, always anchored to a quotation but not itself a quotation</p></person>
      </particDesc>
    </profileDesc>
    <revisionDesc>
      <change when="2026-10-06"
              who="build_paper_edition.py">0 spans located by searching the stored text for the quote's exact words, allowing any whitespace between them</change>
    </revisionDesc>
  </teiHeader>
  <standOff>
    <spanGrp type="tags">
      <span xml:id="t0" type="object_of_study" ana="#object_of_study" resp="#paper">
        <label>A DEFINITION DECIDED BY VOTE, WITH EVERY VOTE PUBLISHED - 107 experts from 29 countries ranking statements about what sarcopenia IS, under a pre-specified agreement threshold, to harmonise six competing definitions into one</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t1" type="research_question" ana="#research_question" resp="#paper">
        <label>which elements belong in the CONCEPT of sarcopenia, decided before and separately from how any of them would be measured</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t2" type="contribution" ana="#contribution" resp="#paper">
        <label>the first global CONCEPTUAL definition of sarcopenia - reduced muscle mass and muscle strength, plus muscle-specific strength, with physical performance placed outside the definition as an outcome and severity excluded entirely</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t3" type="claim_type" ana="#claim_type" resp="#paper">
        <label>method</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t4" type="phenomenon" ana="#phenomenon" resp="#paper">
        <label>a construct whose membership is settled by percentage agreement among named experts, and whose boundary therefore sits at a threshold somebody chose</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t5" type="method" ana="#method" resp="#paper">
        <label>expert-consensus</label>
        <term>expert-consensus</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t6" type="mechanisms" ana="#mechanisms[0]" resp="#tagger" cert="0.95">
        <label>THE ELEMENT THAT MOVED FROM BEING PART OF THE THING TO BEING CAUSED BY IT: `impaired physical performance was accepted as an `OUTCOME` (Sarcopenia increases the risk of impaired physical performance (97.9%)) rather than a `COMPONENT` of sarcopenia (Physical performance should be part of the conceptual definition of sarcopenia (79.4%))`. In EWGSOP 2010 - paper 64 in this corpus - LOW PHYSICAL PERFORMANCE IS CRITERION 3, a diagnostic component. Fourteen years later the same element is a consequence. One relation, two of this corpus&#x27;s edge types, and the vote that moved it is printed to one decimal place</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t7" type="mechanisms" ana="#mechanisms[1]" resp="#tagger" cert="0.95">
        <label>AND THE THRESHOLD IS PRE-SPECIFIED, SO THE BOUNDARY OF THE CONCEPT IS A NUMBER SOMEBODY CHOSE: `low agreement (&lt;70% respondents scoring &gt;=7), moderate agreement (70 to 80%) or strong agreement (&gt;80%). Statements with strong agreement were accepted, and statements with low agreement were REJECTED. Statements with moderate agreement were REINTRODUCED in the subsequent round until consensus was reached.` Muscle-specific strength entered at 80.8%; physical performance was excluded at 79.8%. ONE PERCENTAGE POINT OF A 107-PERSON SURVEY DECIDES WHAT THE DISEASE IS</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t8" type="mechanisms" ana="#mechanisms[2]" resp="#tagger" cert="0.95">
        <label>AND THE PAPER SAYS THE MARGIN OUT LOUD: `The overall support for inclusion of specific strength ... was only slightly higher than our threshold for agreement - 80.8% supported its inclusion when the threshold is 80%, and this statement did not meet the threshold in the first round.` A component of the definition admitted by eight tenths of a point, on a second attempt, and the authors flag it as something the operational phase may undo</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t9" type="mechanisms" ana="#mechanisms[3]" resp="#tagger" cert="0.95">
        <label>AND ONE STATEMENT WAS REJECTED BECAUSE A DIFFERENT ONE FAILED: `Statement 5 `The conceptual definition of sarcopenia should include LEVELS OF SEVERITY` was rejected with an agreement of 77.0% ... AS STATEMENT 5 did not meet the acceptance threshold (&gt;80%), THE REMAINING FOUR STATEMENTS RELATING TO `MARKERS OF THE SEVERITY OF SARCOPENIA` were rejected.` The vote that removed them is not a vote about them</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t10" type="mechanisms" ana="#mechanisms[4]" resp="#tagger" cert="0.95">
        <label>AND ONE OF THE FOUR HAD PASSED: `Physical performance should be A MARKER OF SEVERITY for the conceptual definition of sarcopenia. AGREEMENT: 81.9% (mean score: 7.6 +/- 2.4; answered = 93, skipped = 14).` Above the 80% threshold, and rejected anyway, because the statement it depended on scored 77.0%. A dependency between statements that the threshold rule does not model</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t11" type="mechanisms" ana="#mechanisms[5]" resp="#tagger" cert="0.95">
        <label>AND THE INSTRUMENT WAS DELIBERATELY REMOVED FROM THE QUESTION: `Quotation withheld` A consensus body explicitly preventing the apparatus from shaping the concept - the inverse of leslie2022, where a construct is bounded by a filter pore. And they knew it had been happening</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t12" type="mechanisms" ana="#mechanisms[6]" resp="#tagger" cert="0.95">
        <label>BECAUSE THE EARLIER DISAGREEMENTS WERE PARTLY ABOUT INSTRUMENTS AND PARTLY ABOUT WORDS: `some of the differences in previous definitions were related to disagreements on whether muscle mass should be included in the definition partly due to measurement issues of available techniques ..., whether physical function should be considered as part of the definition or as an outcome, and around the concept of muscle quality. In addition, some terms were not well defined in the literature ... the term `SARCOPENIA` had been used to refer to low muscle mass alone in some studies. For this reason, the first product of the GLIS initiative was A GLOSSARY OF TERMS.` A working group whose first output is a vocabulary, because the vocabulary was the obstacle</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t13" type="mechanisms" ana="#mechanisms[7]" resp="#tagger" cert="0.95">
        <label>AND THE 2010 ADMINISTRATIVE GAP IS HALF CLOSED, IN THE OTHER ORDER: `Sarcopenia also lacks a global and widely accepted definition that can be routinely used in clinical settings, even though an ICD10-CM code for this condition exists.` cruz-jentoft2010 listed the missing ICD-9 code beside the missing definition. THE CODE ARRIVED FIRST - in one national modification, not in the classification itself</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t14" type="mechanisms" ana="#mechanisms[8]" resp="#tagger" cert="0.95">
        <label>AND THE STANDARDS BODY TOLD THEM WHAT WOULD CLOSE THE REST: `The WHO was also contacted, and we were informed that a global definition would facilitate inclusion of sarcopenia in the International Classification of Diseases (at present it is only included in the Clinical Modification version of ICD).` The definition is being written partly IN ORDER TO obtain a code - the vocabulary and its administrative slot pulling on each other, stated by both parties</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t15" type="mechanisms" ana="#mechanisms[9]" resp="#tagger" cert="0.95">
        <label>THE REASON TO AGREE ON A WORD IS ADMINISTRATIVE RECOGNITION: `the World Health Organization (WHO) has yet to include an ICD-10 code for sarcopenia ... A GLOBAL DEFINITION of sarcopenia would ease the adoption of an ICD-10 CODE by WHO, which, in turn, would increase clinical recognition of this condition worldwide.` The chain runs definition -&gt; code -&gt; recognition, and the paper states it in that order.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t16" type="mechanisms" ana="#mechanisms[10]" resp="#tagger" cert="0.95">
        <label>AND CONCEPTUAL AGREEMENT IS SEQUENCED BEFORE OPERATIONAL AGREEMENT, DELIBERATELY: `Quotation withheld.` Every other chain in this corpus revises criteria and thresholds together; this one splits meaning from measurement and does meaning first.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t17" type="mechanisms" ana="#mechanisms[11]" resp="#tagger" cert="0.9">
        <label>SIX DEFINITIONS AND THE REPAIR IS A SEVENTH BODY: `Several groups have proposed definitions of sarcopenia, including the AWGS, the ANZSSFR, the EWGSOP that issued guidelines in 2010 that were REVISED IN 2019; the FNIH Sarcopenia Project, the IWGS and the SDOC`. The response to six competing committees is to convene a global one - the same move ISAPP made for `prebiotic` after five definitions.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t18" type="limitations" ana="#limitations[0]" resp="#tagger" cert="0.95">
        <label>THE ACCEPTED COMPONENTS OVERLAP AND THE PAPER SAYS SO: `Quotation withheld` Muscle-specific strength is strength standardised to size, so voting all three in may have voted the same two in twice - a defect in the definition discovered after the vote that produced it</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t19" type="limitations" ana="#limitations[1]" resp="#tagger" cert="0.95">
        <label>AND THE PROXY THE OPERATIONAL DEFINITION WILL HAVE TO USE IS DISPUTED: `the SDOC found that Quotation withheld, and its associations with sarcopenia-related outcomes (mortality, fractures, falls, disability) are weak or inconsistent.` The concept was defined with the instrument assumed perfect; the instrument is neither perfect nor agreed</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t20" type="limitations" ana="#limitations[2]" resp="#tagger" cert="0.95">
        <label>and the conceptual definition is explicitly NOT usable yet: `The next phase of GLIS will include the OPERATIONALIZATION of the newly developed conceptual definition` - so the paper defines the condition and defers every cut-off point, which is the exact reverse of cruz-jentoft2010, whose Table 5 is nothing but cut-off points</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t21" type="limitations" ana="#limitations[3]" resp="#tagger" cert="0.95">
        <label>and a 52% response rate with a European majority: `The GLIS included reasonable representation of men and women, and geography, although most of the respondents were from Europe. The total response rate of GLIS was 52% ... which could have been higher. Nevertheless, we retained 100% (107/107) of participants through both rounds`. Both conceded in the strengths paragraph</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t22" type="controls" ana="#controls[0]" resp="#tagger" cert="0.95">
        <label>instructing the experts to ASSUME PERFECT, FEASIBLE ASSESSMENTS of each listed measure existed</label>
        <note>eliminates: answers skewed by which measurements happen to be accurate or available - the apparatus deciding the concept · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t23" type="controls" ana="#controls[1]" resp="#tagger" cert="0.95">
        <label>pre-specifying the agreement thresholds (&lt;70% / 70-80% / &gt;80%) before the survey ran</label>
        <note>eliminates: a threshold chosen after the votes were seen · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t24" type="controls" ana="#controls[2]" resp="#tagger" cert="0.95">
        <label>a glossary of sarcopenia terms published BEFORE the Delphi statements were voted on</label>
        <note>eliminates: experts agreeing on a statement while meaning different things by its words - &#x27;many different definitions of muscle quality were used in previous studies&#x27; · outcome: partial</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t25" type="concepts" ana="#concepts[0]" resp="#paper" cert="0.95">
        <label>sarcopenia</label>
        <term>sarcopenia</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t26" type="concepts" ana="#concepts[1]" resp="#paper" cert="0.95">
        <label>impaired physical performance</label>
        <term>impaired physical performance</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t27" type="concepts" ana="#concepts[2]" resp="#paper" cert="0.95">
        <label>muscle-specific strength</label>
        <term>muscle-specific strength</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t28" type="concepts" ana="#concepts[3]" resp="#paper" cert="0.95">
        <label>muscle mass</label>
        <term>muscle mass</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t29" type="concepts" ana="#concepts[4]" resp="#paper" cert="0.95">
        <label>lean mass</label>
        <term>lean mass</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t30" type="concepts" ana="#concepts[5]" resp="#paper" cert="0.95">
        <label>Delphi</label>
        <term>Delphi</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t31" type="concepts" ana="#concepts[6]" resp="#paper" cert="0.95">
        <label>gold standard</label>
        <term>gold standard</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t32" type="concepts" ana="#concepts[7]" resp="#paper" cert="0.95">
        <label>conceptual definition</label>
        <term>conceptual definition</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t33" type="senses" ana="#senses[0]" resp="#tagger" cert="0.95">
        <label>`sarcopenia` (GLIS 2024, CONCEPTUAL) - `the concurrent combination of reduced muscle mass and muscle strength`, plus muscle-specific strength; a generalised disease of skeletal muscle, potentially reversible, the same in clinic and research, and NOT varying by setting, age or condition</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t34" type="senses" ana="#senses[1]" resp="#tagger" cert="0.95">
        <label>`physical performance` - IN the 2010 definition as diagnostic criterion 3, OUT of the 2024 one at 79.4%, and readmitted as an OUTCOME at 97.9%</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t35" type="senses" ana="#senses[2]" resp="#tagger" cert="0.95">
        <label>`muscle-specific strength` - `strength standardised to muscle size`; admitted to the definition at 80.8% against an 80% threshold, having failed round 1</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t36" type="senses" ana="#senses[3]" resp="#tagger" cert="0.95">
        <label>`conceptual definition` vs `operational definition` - GLIS separates them ON PURPOSE and produces only the first, deferring every measure and cut-off point to a later phase</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t37" type="senses" ana="#senses[4]" resp="#tagger" cert="0.95">
        <label>`sarcopenia` - SIX RIVAL DEFINITIONS, EACH WITH AN INSTITUTIONAL OWNER, ENUMERATED IN ONE PARAGRAPH: AWGS, ANZSSFR, EWGSOP (2010, revised 2019), the FNIH Sarcopenia Project, IWGS, and SDOC. Not a term with two senses - a term with six committees.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t38" type="senses" ana="#senses[5]" resp="#tagger" cert="0.95">
        <label>`gold standard` - A THING TO BE BUILT, NOT FOUND: GLIS was formed `in an attempt to harmonise these competing definitions into one unifying common classification that would be used as the gold standard`. In lotvall2014 the gold standard is DENIED to exist; in doyle2019 it is AWARDED to an incumbent; here it is a DELIVERABLE.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t39" type="alternatives" ana="#alternatives.claim_type" resp="#tagger" cert="0.6">
        <label>claim_type: method</label>
        <note>a second reading reaching the same value. Recorded: method — note: A BLIND second reading by the project on 2026-08-25: the record&#x27;s own claim type/method/phenomenon were not looked at until every value here was written and substring-verified. Not applied - a person decides. Sampling frame: the 504 staged records carrying no alternatives block, so this never re-measures the 202. All 11 records with 130+ tags were taken as a census and 19 more spread one per discipline across 22 disciplines - the dense non-neuroscience cell is the one the 202 do not contain (inside them, 94-100% of the densest bands are neuroscience; among these 11, one is).,</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t40" type="alternatives" ana="#alternatives.method" resp="#tagger" cert="0.9">
        <label>method: delphi-consensus</label>
        <note>a second reading DIFFERING from the recorded value. Recorded: expert-consensus — note: A BLIND second reading by the project on 2026-08-25: the record&#x27;s own claim type/method/phenomenon were not looked at until every value here was written and substring-verified. Not applied - a person decides. Sampling frame: the 504 staged records carrying no alternatives block, so this never re-measures the 202. All 11 records with 130+ tags were taken as a census and 19 more spread one per discipline across 22 disciplines - the dense non-neuroscience cell is the one the 202 do not contain (inside them, 94-100% of the densest bands are neuroscience; among these 11, one is).,</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t41" type="claim_relations" ana="#claim_relations[0]" resp="#tagger" cert="0.95">
        <label>extends → the six competing regional definitions of sarcopenia - AWGS, ANZSSFR, EWGSOP (2010, revised 2019), FNIH, IWGS and SDOC - which GLIS was formed to harmonise into one classification</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t42" type="claim_relations" ana="#claim_relations[1]" resp="#tagger" cert="0.95">
        <label>critiques → EWGSOP 2010&#x27;s inclusion of physical performance as a diagnostic criterion, which this Delphi rejects as a component at 79.4% and readmits as an outcome at 97.9%</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t43" type="concept_edges" ana="#concept_edges[0]" resp="#tagger" cert="0.85">
        <label>sarcopenia —causes→ impaired physical performance</label>
        <term>sarcopenia</term>
        <term>impaired physical performance</term>
        <note>the relation itself is separately evidenced · strength of the relation: 0.95 · note: THE EDGE THAT REPLACED A part-of. EWGSOP 2010 made low physical performance diagnostic CRITERION 3 - part of the condition. GLIS 2024 puts the same element outside the definition and back in as a consequence: `impaired physical performance was accepted as an `OUTCOME` ... rather than a `COMPONENT` of sarcopenia`. The two readings differ by 18.5 percentage points in one survey of 107 people · the relation stated: accepted as an OUTCOME of sarcopenia at 97.9%, having been rejected as a COMPONENT of it at 79.4% in the same survey</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t44" type="concept_edges" ana="#concept_edges[1]" resp="#tagger" cert="0.95">
        <label>muscle-specific strength —part-of→ sarcopenia</label>
        <term>muscle-specific strength</term>
        <term>sarcopenia</term>
        <note>the relation itself is separately evidenced · strength of the relation: 0.9 · note: &#x27;WOULD INCLUDE…&#x27;. Weight 0.9: the paper&#x27;s own phrase is &#x27;part of the conceptual DEFINITION of sarcopenia&#x27;, and this corpus can say that something is part of a THING but not that it is part of a DEFINITION - the same gap cruz-jentoft2010 exposed with &#x27;sarcopenia is one of the elements of the proposed definition for cachexia&#x27;. Twice in two records · the relation stated: voted a COMPONENT of the conceptual definition at 80.8%, against a threshold of 80%</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t45" type="concept_edges" ana="#concept_edges[2]" resp="#tagger" cert="0.95">
        <label>lean mass —distinct-from→ muscle mass</label>
        <term>lean mass</term>
        <term>muscle mass</term>
        <note>the relation itself is separately evidenced · strength of the relation: 0.95 · note: &#x27;SUBSTANTIAL DISAGREEMENT…&#x27; The concept was voted on with the instruments assumed perfect; this is the instrument that will actually be used · the relation stated: lean mass is the available proxy and DOES NOT DIRECTLY MEASURE muscle mass</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t46" type="content_tags" ana="#content_tags.findings[0]" resp="#tagger" cert="0.95">
        <label>impaired physical performance was accepted as an outcome (97.9%) rather than a component (79.4%) of sarcopenia</label>
        <term>impaired physical performance was accepted as an outcome (97.9%) rather than a component (79.4%) of sarcopenia</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t47" type="content_tags" ana="#content_tags.findings[1]" resp="#tagger" cert="0.95">
        <label>pre-specified thresholds: over 80% agreement accepted, 70-80% reintroduced, under 70% rejected</label>
        <term>pre-specified thresholds: over 80% agreement accepted, 70-80% reintroduced, under 70% rejected</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t48" type="content_tags" ana="#content_tags.findings[2]" resp="#tagger" cert="0.95">
        <label>because statement 5 missed the 80% threshold (77.0%), the four severity-marker statements were rejected</label>
        <term>because statement 5 missed the 80% threshold (77.0%), the four severity-marker statements were rejected</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t49" type="content_tags" ana="#content_tags.findings[3]" resp="#tagger" cert="0.95">
        <label>THE INSTRUMENT WAS DELIBERATELY REMOVED FROM THE QUESTION: `To avoid the issue that answers might be skewed by the accuracy and lack of currently available measurement methods, experts were asked to assume that perfect, feasible assessments of each listed measure existed`</label>
        <term>THE INSTRUMENT WAS DELIBERATELY REMOVED FROM THE QUESTION: `To avoid the issue that answers might be skewed by the accuracy and lack of currently available measurement methods, experts were asked to assume that perfect, feasible assessments of each listed measure existed`</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t50" type="content_tags" ana="#content_tags.findings[4]" resp="#tagger" cert="0.95">
        <label>sarcopenia lacks a widely accepted clinical definition even though an ICD-10-CM code exists</label>
        <term>sarcopenia lacks a widely accepted clinical definition even though an ICD-10-CM code exists</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t51" type="content_tags" ana="#content_tags.findings[5]" resp="#tagger" cert="0.95">
        <label>AND THE ACCEPTED COMPONENTS MAY COUNT THE SAME THING TWICE: `how to consider these potentially overlapping components, where muscle mass and strength may be the same components included in the specific strength measure`</label>
        <term>AND THE ACCEPTED COMPONENTS MAY COUNT THE SAME THING TWICE: `how to consider these potentially overlapping components, where muscle mass and strength may be the same components included in the specific strength measure`</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t52" type="content_tags" ana="#content_tags.definitions[0]" resp="#tagger" cert="0.95">
        <label>`the concurrent combination of reduced muscle mass and muscle strength` ... `a generalised disease of skeletal muscle` ... `should not vary by setting of care, age or condition, or use (clinic vs. research)` ... `a potentially reversible disease`</label>
        <term>sarcopenia</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t53" type="content_tags" ana="#content_tags.definitions[1]" resp="#tagger" cert="0.95">
        <label>`strength standardised to muscle size` - `an attempt to blend measurements of muscle mass and strength in a single component`, admitted at 80.8%</label>
        <term>muscle-specific strength</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t54" type="content_tags" ana="#content_tags.quantities[0]" resp="#tagger" cert="0.95">
        <label>below the pre-specified 80% threshold, so physical performance is not part of the condition</label>
        <term>agreement, physical performance as a COMPONENT</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t55" type="content_tags" ana="#content_tags.quantities[1]" resp="#tagger" cert="0.95">
        <label>the same element, the same survey, as a consequence instead of a part</label>
        <term>agreement, sarcopenia INCREASES THE RISK of impaired physical performance</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t56" type="content_tags" ana="#content_tags.quantities[2]" resp="#tagger" cert="0.95">
        <label>`only slightly higher than our threshold for agreement ... and this statement did not meet the threshold in the first round`</label>
        <term>agreement, muscle-specific strength as a component</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t57" type="content_tags" ana="#content_tags.quantities[3]" resp="#tagger" cert="0.95">
        <label>`AS STATEMENT 5 did not meet the acceptance threshold (&gt;80%), THE REMAINING FOUR (50%) STATEMENTS RELATING TO MARKERS OF THE SEVERITY OF SARCOPENIA WERE REJECTED`</label>
        <term>agreement, levels of severity in the definition</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t58" type="content_tags" ana="#content_tags.quantities[4]" resp="#tagger" cert="0.95">
        <label>rejected because its parent statement scored 77.0% - the vote that removed it is not a vote about it</label>
        <term>agreement, physical performance as a MARKER OF SEVERITY</term>
        <note>value source note: THE VALUE DRAWS ON THE PAPER BEYOND THIS QUOTE: the 80% threshold is set in the methods (&#x27;strong agreement (&gt;80%)&#x27;), not in this quote, and so is the reason the statement was still rejected.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t59" type="content_tags" ana="#content_tags.quantities[5]" resp="#tagger" cert="0.95">
        <label>`although most of the respondents were from Europe`</label>
        <term>Delphi panel</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t60" type="content_tags" ana="#content_tags.statistics[0]" resp="#tagger" cert="0.95">
        <label>the share of respondents scoring 7 or more on an 11-point Likert scale - the statistic that decides membership of the concept</label>
        <term>percentage agreement</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t61" type="content_tags" ana="#content_tags.variables[0]" resp="#tagger" cert="0.95">
        <label>accepted into the conceptual definition at 93.1%, the highest of the three components</label>
        <term>muscle strength</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
    </spanGrp>
  </standOff>
  <text>
    <body>
      <p><note type="rights">The full text of this article is not redistributable, so it is
      not included here. The evidence sentences are withheld with it; the tag layer and its
      grounding status remain. The article itself is at https://doi.org/10.1093/ageing/afae052.</note></p>
    </body>
  </text>
</TEI>
